Literature DB >> 27628320

Studies on the Contribution of Cox-2 Expression in the Progression of Oral Squamous Cell Carcinoma and H-Ras Activation.

Abdolkarim Moazeni-Roodi1, Abdolamir Allameh2, Iraj Harirchi3, Maziar Motiee-Langroudi3, Ata Garajei4.   

Abstract

The aim of this study was to investigate the relationship between the H-ras and Cox-2 gene expression in tumors from Iranian Oral Squamous Cell Carcinoma (OSCC) patients. Fresh tumor biopsies removed from oral cavity were collected from 67 new cases. Total RNA was extracted from biopsies and processed for quantification of H-ras and Cox-2 specific RNA expression using real-time PCR (QPCR). In addition, 59 gingival biopsies from apparently normal individuals were processed for QPCR assays. The results showed that Cox-2 expression at mRNA levels was at minimal levels in normal gingival biopsies. However, there was a surge in Cox-2 expression in tumor tissues (11.5 fold, p < 0.0001). Cox-2 expression was elevated depending on the tumor grade and there was a 1.7 fold increase (p = 0.003) in tumors diagnosed as MD/PD compared to that pathologically diagnosed as WD. This inflammatory marker was increased more significantly in smoker patients compared to non-smoker matching group. The H-ras expression at mRNA levels was significantly higher in OSCC samples compared to normal gingival (3 fold; p = 0.044). This expression was significantly higher in tumors diagnosed as MD/PD compared to WD (1.59 fold, p = 0.033). In conclusion, we found a correlation between H-ras expression and Cox-2 induction in OSCC tissue, suggesting that together these genes are contributing to cancer progression. Cox-2 is an early event in cancers of mucosal epithelial cells and a surge in Cox-2 expression in OSCC could be partly due to pro-inflammatory factors such as smoking.

Entities:  

Keywords:  Cox-2; H-ras; Iran; OSCC; Oncogene; Smoking

Mesh:

Substances:

Year:  2016        PMID: 27628320     DOI: 10.1007/s12253-016-0114-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

Review 1.  Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).

Authors:  Fumin Chang; Linda S Steelman; John G Shelton; John T Lee; Patrick M Navolanic; William L Blalock; Richard Franklin; James A McCubrey
Journal:  Int J Oncol       Date:  2003-03       Impact factor: 5.650

Review 2.  Ras oncogenes in oral cancer: the past 20 years.

Authors:  Avaniyapuram Kannan Murugan; Arasambattu Kannan Munirajan; Nobuo Tsuchida
Journal:  Oral Oncol       Date:  2012-01-11       Impact factor: 5.337

Review 3.  Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

4.  Smokeless tobacco, viruses and oral cancer.

Authors:  Lars Sand; Mats Wallström; Jan-Michaél Hirsch
Journal:  Oral Health Dent Manag       Date:  2014-06

5.  COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.

Authors:  Tie-Jun Li; Jun Cui
Journal:  Asian Pac J Trop Med       Date:  2013-08       Impact factor: 1.226

Review 6.  Prostaglandins and inflammation.

Authors:  Emanuela Ricciotti; Garret A FitzGerald
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05       Impact factor: 8.311

7.  Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.

Authors:  M Pandey; O Prakash; W S Santhi; C S Soumithran; R M Pillai
Journal:  Int J Oral Maxillofac Surg       Date:  2008-03-19       Impact factor: 2.789

8.  Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response.

Authors:  N Hamzic; A Blomqvist; C Nilsberth
Journal:  J Neuroendocrinol       Date:  2013-03       Impact factor: 3.627

9.  Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.

Authors:  Abdolamir Allameh; Yousef Rasmi; Siavosh Nasseri-Moghaddam; Seyed Mohammad Tavangar; Roya Sharifi; Masoud Sadreddini
Journal:  Cancer Epidemiol       Date:  2009-06-24       Impact factor: 2.984

10.  Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression.

Authors:  Christine E Wong; Jennifer S Yu; David A Quigley; Minh D To; Kuang-Yu Jen; Phillips Y Huang; Reyno Del Rosario; Allan Balmain
Journal:  Genes Dev       Date:  2013-03-15       Impact factor: 11.361

View more
  4 in total

1.  Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil.

Authors:  N-V-F Bezerra; K-L-F Leite; M-M-D de Medeiros; M-L Martins; A-M-R Cardoso; P-M Alves; W-W-N Padilha; Y-W Cavalcanti
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-05-01

2.  Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.

Authors:  Nand Kishor Roy; Javadi Monisha; Ganesan Padmavathi; H Lalhruaitluanga; Nachimuthu Senthil Kumar; Anuj Kumar Singh; Devivasha Bordoloi; Munindra Narayan Baruah; Gazi Naseem Ahmed; Imliwati Longkumar; Frank Arfuso; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2019-06-27

Review 3.  Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis.

Authors:  Ellen Frejborg; Tuula Salo; Abdelhakim Salem
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 4.  Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis.

Authors:  Pamela Pignatelli; Federica Maria Romei; Danilo Bondi; Michele Giuliani; Adriano Piattelli; Maria Cristina Curia
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.